Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: A prospective study

Lancet

Volumn 356, Issue 9226, 2000, Pages 297-302

  Nosten, F ^a,b,d   Van Vugt, M ^a,b,c   Price, R ^a,b,d   Luxemburger, C ^a,b,d   Thway, K L ^a   Brockman, A ^a,b,d   McGready, R ^a,b,d   Ter Kuile, F ^c,e   Looareesuwan, S ^b   White, N J ^b,d  

^a SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; FANSIDAR; MEFLOQUINE;

ADOLESCENT; ARTICLE; CHILD; DRUG RESISTANCE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; THAILAND;

EID: 0034702506     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02505-8     Document Type: Article

References (24)

1. Nosten F., Luxemburger C., ter Kuile F.et al. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. J Infect Dis. 170:1994;971-977.
2. Luxemburger C., Ricci F., Nosten F., Raimond D., Bathet S., White N.J. The epidemiology of severe malaria in an area of low transmission in Thailand. Trans R Soc Trop Med Hyg. 91:1997;256-262.
3. Luxemburger C., Thwai K.L., White N.J.et al. The epidemiology of malaria in a Karen population on the western border of Thailand. Trans R Soc Trop Med Hyg. 90:1996;105-111.
4. Nosten F., ter Kuile F., Chongsuphajaisiddhi T.et al. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet. 337:1991;1140-1143.
5. ter Kuile F., Nosten F., Thieren M.et al. High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria. J Infect Dis. 166:1992;1393-1400.
6. Brockman A., Paul R.E., Anderson T.et al. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the north western border of Thailand. Am J Trop Med Hyg. 60:1999;14-21.
7. Nosten F., ter Kuile F., Maelankirri L., Decludt B., White N.J. Malaria during pregnancy in an area of unstable endemicity. Trans R Soc Trop Med Hyg. 85:1991;424-429.
8. Price R.N., Nosten F., Luxemburger C.et al. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg. 91:1997;574-577.
9. ter Kuile F., Dolan G., Nosten F.et al. Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria. Lancet. 341:1993;1044-1049.
10. Childs G.E., Pang L., Wimonwattratee T.et al. In-vitro mefloquine resistance of Plasmodium falciparum isolated from the Burmese border region of Thailand. SE Asia J Trop Med Public Health. 18:1987;438-443.
11. Webster H.K., Boudreau E.F., Pavanand K., Yongvanitchit K., Pang L.W. Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method. Am J Trop Med Hyg. 34:1985;228-235.
12. Brockman A, Price RN, Van Vugt M, et al. Plasmodiumn falciparum antimalarial drug susceptibility on the northwestern border of Thailand during 5 years of extensive artsunate-mefloquine use. Trans R Soc Med Hyg 2000 (in press).
13. Wirtz R.A., Charoenvit Y., Burkot T.R.et al. Evaluation of monoclonal antibodies against Plasmodium vivax sporozoites for ELISA development. Med Vet Entomol. 5:1991;17-22.
14. Wirtz R.A., Sattabongkot J., Hall T., Burkot T.R., Rosenberg R. Development and evaluation of an enzyme-linked immunosorbent assay for Plasmodium vivax-VK247 sporozoites. J Med Entomol. 29:1992;854-857.
15. Wirtz R.A., Zavala F., Charoenvit Y.et al. Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development. Bull World Health Organ. 65:1987;39-45.
16. Nosten F., Imivithaya S., Vincenti M.et al. Malaria on the Thai-Burmese border: treatment of 5182 patients with mefloquine-sulfadoxine-pyrimethamine combination. Bull World Health Organ. 65:1987;891-896.
17. Price R.N., Nosten F., Luxemburger C.et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet. 347:1996;1654-1658.
18. Nosten F., Hien T.T., White N.J. Use of artemisinin derivatives for the control of malaria. Med Trop (Mars). 58:1998;45-49.
19. Sharma Y.D., Biswas S., Pillai C.R., Ansari M.A., Adak T., Devi C.U. High prevalence of chloroquine resistant Plasmodium falciparum infection in Rajasthan epidemic. Acta Trop. 62:1996;135-141.
20. Dolan G., ter Kuile F., Jacoutot V.et al. Bed nets for the prevention of malaria and anaemia in pregnancy. Trans R Soc Trop Med Hyg. 87:1993;620-626.
21. Luxemburger C., Perea W.A., Delmas G., Pruja C., Pecoul B., Moren A. Permethrin-impregnated bed nets for the prevention of malaria in schoolchildren on the Thai-Burmese border. Trans R Soc Trop Med Hyg. 88:1994;155-159.
22. White N.J. Preventing antimalarial drug resistance through combinations. Drug Res Update. 1:1998;3-9.
23. White N.J., Nosten F., Looareesuwan S., Marsh K.et al. Malaria. averting a disaster Lancet. 353:1999;1965-1967.
24. Von Seidlein L., Milligan P., Pinder P., Bojang K.et al. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet. 355:2000;352-357.